Join AISAP’s Webinar: Real-World Cases: AI Impacting Outcomes in Emergency, Internal, and Primary Care.

Transforming the
Point-of-Care with expert-level AI

AISAP redefines the standard of care with FDA-cleared diagnostic algorithms, embedded in an AI operating system for any Point-of-care ultrasound device
Request a Demo
Research Partners

Our mission is to deliver the highest standard of care in real time, where it is needed most

Proven Solution

FDA-cleared

AISAP’s FDA‑cleared platform is in use across health systems, hospitals, and clinics worldwide.
Explore Trust Hub

Shorten time to diagnosis

Get rapid, expert-level results instantly at the point of care

Reduce length of stay

Enables timely discharge, reducing LOS and avoiding unnecessary expenses and use of hospital imaging.

Early detection of structural heart disease

Identify heart disease early with expert-level AI results

Avoid unnecessary patients transfers

Avoid patient transfers by having the exam done right at the bed side.

POCUS OS™

A seamless ,all-in-one platform for all your POCUS needs

CardiacAI

FDA-cleared algorithms
Valvular pathology
- Mitral Regurgitation
- Tricuspid Regurgitation
- Aortic Regurgitation
- Aortic Stenosis
Measuements
- Left Ventricular Ejection Fraction
- Ventricular Dimensions
- Right Ventricle Fractional Area Change
- Atrial areas
- Ascending aorta
- Inferior Vena Cava maximal diameter

AbdomenAI

* FDA clearance in progress
- Kidney size
- Hydronephrosis
- Spleen Size
- Gallbladder  
- Cholecystitis
- Bladder volume

VascularAI

*FDA clearance in progress
- Abdominal aortic diameter
- Carotid diameter
- Deep vein thrombosis (DVT)

LungsAI

*Algorithm training phase
- Pleural effusion
- Consolidation B-lines
- Pneumothorax

POCUS-OS™
An All-in-One Platform

AISAP offers a comprehensive point‑of‑care ecosystem

Boost revenue

Increase billing to 95% and transform any image to billable encounters.

Cut reporting time with AI

Smart reporting reduces reporting time by up to 90%.

Seamless integration

Works with any ultrasound device, PACS and EMR to fit existing workflows.

Flexible deployment

Secure “on‑premise to cloud” architecture bridges point‑of‑care devices and hospital systems.

Expand capacity

Short training enables any caregiver to scan confidently.

Standardize quality

Built-in accreditation and QA tools ensure consistent, high-quality care.

The AISAP Workflow

POCUS
PACS
AI Results
Reoprt
EMR
POCUS-OS™
1
POCUS Integration
Integrates seamlessly with any Point-of-Care Ultrasound device already in use.
2
PACS on Cloud
Provides a dedicated PACS that anonymizes DICOM files and stores them securely in the cloud or on-premise.
3
AI Results
Delivers bedside diagnoses and measurements using FDA-cleared AI models.
4
Reporting
Automatically generates billable reports for user approval.
5
EMR Integration
Finalized reports are automatically sent to the EMR.

Every person matters

Male
·
89
Severe MR
LVEF 18%

A 89-year-old man with congestive heart failure and a TAVI performed four months earlier presented with shortness of breath and desaturation. A bedside AISAP exam revealed EF 18%, severe MR, severe TR, and an enlarged right atrium.A formal echocardiogram confirmed these findings, and he was referred for MitraClip as part of his comprehensive management plan.

Female
·
75
PEFF

A 75-year-old woman with metastatic breast cancer arrived at the ED with worsening weakness and shortness of breath. AISAP revealed a large pericardial effusion, leading to the diagnosis of cardiac tamponade. She underwent urgent pericardial drainage, with 650 mL removed, resulting in rapid stabilization.

Female
·
39
LVEF 18 %
Severe MR

A 39-year-old woman with APLA syndrome returned to the ED three weeks after an emergency C-section with recurrent chest pain. Pulmonary embolism had been ruled out during a visit two days earlier, and an echocardiogram performed two months prior was normal (EF 60%).
A bedside AISAP exam revealed severe LV dysfunction, moderate RV dysfunction, severe MR, and mild pericardial effusion. These findings led to an urgent formal echocardiography and cardiology review, which established the diagnosis of postpartum cardiomyopathy.

Female
·
47
LVEF 14 %
Severe MR

A 47-year-old woman with obesity, hypertension, dyslipidemia, and a history of chronic heart failure presented with shortness of breath, peripheral edema, and clinical signs of deterioration. Without on-site echocardiography, her worsening status could not be objectively assessed. A bedside AISAP exam revealed EF 14%, severe mitral regurgitation, and severe tricuspid regurgitation, confirming significant decline from her prior evaluation. In this low-resource setting, AISAP provided the essential diagnostic clarity needed to guide timely management during an acute heart failure exacerbation.

Female
·
46
RVF 34 %
RA Area 26.2 cm²

A 46-year-old woman was admitted with palpitations, dizziness, and persistent tachycardia. Management for suspected ACS did not improve her condition for several days. A bedside AISAP exam revealed reduced RV Fractional Area Change and a dilated right atrium, findings that raised concern for pulmonary embolism.
With no on-site CT and expected delays for external imaging, AISAP provided supportive information that guided a change to therapeutic anticoagulation. The patient showed clinical improvement, and a subsequent CT scan confirmed the presence of PE.

Female
·
95
Severe AS
LVEF 45%

A 95-year-old woman with no prior cardiac history arrived at the ED with shortness of breath. A bedside exam using AISAP identified severe aortic stenosis and left ventricular dysfunction, providing immediate diagnostic clarity and guiding referral for further evaluation that led to TAVI approval for the patient.

Male
·
47
LVEF 27 %

A 47-year-old man with a history of ischemic heart disease presented to the ED with chest pain. A bedside exam using AISAP identified severe heart failure with an ejection fraction of 27% within minutes, enabling swift referral to cardiology and timely, targeted treatment.

Male
·
70
LVEF 39 %

A 70-year-old man, healthy and recently after mitral valve replacement, arrived at the ED with new leg edema and shortness of breath. A bedside exam using AISAP revealed new heart failure within minutes, giving the care team immediate clarity and enabling rapid, targeted treatment.

Male
·
70
LVEF 19 %

A 70-year-old oncology patient underwent repeat stoma surgery and collapsed mid-procedure with hypotension and bradycardia, briefly stabilized with epinephrine. In recovery, she remained dependent on vasopressors, initially suspected to be hypovolemic. A bedside exam using AISAP revealed severe left ventricular dysfunction, prompting immediate cardiology consultation and full echocardiography. The patient was rushed to the cath lab; coronaries were normal, and she was ultimately diagnosed with Takotsubo cardiomyopathy.

Hear From Our Partners

"Structural heart disease and heart failure are the leading causes of hospitalization and morbidity in the U.S. Enabling a wide variety of qualified physicians to quickly and accurately diagnose these conditions at the bedside could lead to earlier detection and treatment, and better patient outcomes."
"Aortic stenosis is life-threatening if left untreated. AISAP dramatically improves early detection of structural heart disease and enables timely interventions for patients who might otherwise go undiagnosed. This game-changing technology improves outcomes and lowers healthcare costs."
"With AISAP, we can deliver AI interpretation for early cardiac disease detection, securely store our data, and give participants clear reports to guide safe follow-up care."
"Having immediate expert-level results reduces observation time and frees capacity for more acute cases."
"AI-powered interpretation, combined with structured reporting, has made it possible for us to identify structural heart disease earlier in asymptomatic participants, a capability that can truly save lives."